Davangere P. Devanand, MBBS
Professor of Psychiatry (in Neurology and in the Gertrude H. Sergievsky Center) at CUMC
Director of Geriatric Psychiatry
Dr. D. P. Devanand is Professor of Psychiatry and Neurology at the Columbia University Medical Center. He completed medical school at Christian Medical College, Vellore, in India, and trained in psychiatry at the National Institute of Mental Health and Neurosciences, Bangalore, India.
He completed psychiatry residency training at S.U.N.Y. Upstate Medical Center, Syracuse, NY, and Yale University School of Medicine in New Haven, CT. He then did a clinical research fellowship in Biological Psychiatry at Columbia University, and has continued on the faculty at Columbia University since 1987. Currently, he is Director of the DIvision of Geriatric Psychiatry, Co-Director of the Memory Disorders Center, and Co-Director of the Adult and Late Life Depression Clinic at the New York State Psychiatric Institute. His research studies involve Alzheimer’s disease and geriatric depression.
His research helped to define the clinical features and treatment response in elderly patients with dysthymic disorder, a chronic depressive illness. He pioneered studies on the interface between depression and cognitive impairment in the elderly, and is well-known for his research into early diagnostic markers of Alzheimer’s disease and the treatment of psychosis and agitation in this disorder. He has published research articles in major journals including a landmark study on antipsychotic discontinuation in Alzheimer’s disease in the New England Journal of Medicine, and articles in several journals including JAMA, Annals of Neurology, Neurology, Archives of General Psychiatry, and American Journal of Psychiatry. He has been principal investigator on several research grants from the National Institute of Aging and the National Institute of Mental Health. He has also been funded by the Department of Defense, Alzheimer’s Association, NARSAD, and the Dana Foundation.
He has received the International Psychogeriatric Association Research Award, the American Association of Geriatric Psychiatry Distinguished Investigator Award, and the American Psychiatric Association Jack Weinberg Memorial Award in geriatric psychiatry. He has published over 275 research papers and articles, and is the author of three books.
Herbert Pardes Building of the New York State Psychiatric Institute
1051 Riverside Drive
Unit 126 New York, NY 10032
Phone: (646) 774-8658
Fax: (646) 774-8633
Public Transportation: Yes
Disabled Access: Yes
Research interests include treatment strategies for mild cognitive impairment and Alzheimer's disease, including treatment of psychosis and agitation in these disorders. Other interests include early diagnostic markers of Alzheimer's disease, and the interface between depression and cognitive impairment.
1) Study of olfactory identification deficits in the prediction of response to treatment with FDA-approved cholinesterase inhibitors in patients with mild cognitive impairment and mild to moderate Alzheimer's disease.
2) Study of low dose lithium to treat patients with Alzheimer's disease who develop symptoms of agitation, aggression, delusions or hallucinations.
Both studies are funded by the National Institute of Aging, a branch of the National Institutes of health.